New Onset (Incidence) of Epilepsy and Seizures in Nursing Home Residents.
Ilo E Leppik, Angela K Birnbaum, Kenneth Svensden and 1 others
PMID 35779573WHAT IT FOUND
New epilepsy or seizure diagnoses occurred at 16.42 per 1000 patient-years in nursing home residents.
The highest rates were in those with brain tumors, head injury, hemiplegia, or stroke.
Key findings
01The incidence of new epilepsy or seizure diagnoses was 16.42 per 1000 patient-years.
02The highest incidence of new epilepsy or seizure diagnoses was in residents with brain tumors, head injury, hemiplegia, or stroke.
03The study did not track later seizures, antiseizure medication use, or its consequences, so it cannot show which residents benefit from treatment.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Epilepsy or seizure diagnosis was based on nursing home assessment records and ICD-9 codes, not clinical adjudication, so coding may have varied between homes. Convulsions may not have been witnessed or recorded, so some new seizures were likely missed. Residents dropped out of the analysis each year because they developed a diagnosis, died, were discharged, or lacked complete records, which may have undercounted incidence. Some residents may have had unrecognized seizures before admission, which could have inflated the first-year incidence. The study did not measure later seizures, antiseizure medication use, medication side effects, or economic impact. Because it was a cohort of survivors, the authors say it likely underrepresents the actual incidence.
Declared interests
The work was supported in part by NIH/NIA and ASPH/CDC. Dr. Leppik received honoraria for consulting from Sunovion and for speaking from Eisai.
The easy way to misread this
Do not read these incidence rates as a reason to start antiseizure medication after one seizure. The study did not track later seizures, medication use, or outcomes, and it says the risk and benefit balance of treating all seizures is unknown.